<p>Flu viruses are highly changeable so elderly people and pregnant women, who are particularly vulnerable to the illness, are currently given new vaccinations each year to ensure they are protected.<br /><br />But, the scientists say that the new flu vaccine, Flu-v vaccine, which needs to be administered only once, has been found to be effective against a number of different types of influenza virus, including the avian flu and pandemic swine flu strains in a clinical trial. They are now planning to conduct a large-scale clinical trial and hope to have a vaccine available for widespread use in three to five years’ time.<br /><br />“This vaccine clearly has a biological effect worthy of further investigation, particularly with respect to the broadness of the response. In the 2009 swine flu pandemic it was several months before a vaccine was available. “A universal vaccine could end that wait and also reduce the need for people to have vaccines each year against seasonal flu,” Prof John Oxford, a virologist at St Barts and Royal London Hospital and scientific director of Retroscreen Virology, who conducted the clinical trial, said.<br /></p>
<p>Flu viruses are highly changeable so elderly people and pregnant women, who are particularly vulnerable to the illness, are currently given new vaccinations each year to ensure they are protected.<br /><br />But, the scientists say that the new flu vaccine, Flu-v vaccine, which needs to be administered only once, has been found to be effective against a number of different types of influenza virus, including the avian flu and pandemic swine flu strains in a clinical trial. They are now planning to conduct a large-scale clinical trial and hope to have a vaccine available for widespread use in three to five years’ time.<br /><br />“This vaccine clearly has a biological effect worthy of further investigation, particularly with respect to the broadness of the response. In the 2009 swine flu pandemic it was several months before a vaccine was available. “A universal vaccine could end that wait and also reduce the need for people to have vaccines each year against seasonal flu,” Prof John Oxford, a virologist at St Barts and Royal London Hospital and scientific director of Retroscreen Virology, who conducted the clinical trial, said.<br /></p>